查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1858698

人類纖維蛋白原：全球市佔率排名、總銷售額和需求預測（2025-2031年）

Human Fibrinogen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 93 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球人類纖維蛋白原市場規模估計為12.59億美元，預計到2031年將達到25.62億美元，在2025-2031年的預測期內，複合年成長率為10.5%。

本研究報告全面評估了人類纖維蛋白原的跨境產業佈局、資本配置模式、區域經濟相互依存關係，以及近期關稅調整和國際供應鏈重組策略措施。

人類纖維蛋白原是一種高度純化的血漿蛋白製劑，來自人類血漿（主要成分為纖維蛋白原），或透過重組技術生產。纖維蛋白原在血液凝固過程中起著關鍵作用，它經凝血酶轉化為纖維蛋白，形成血塊以止血。纖維蛋白原濃縮物主要用於治療先天性或後天性纖維蛋白原缺乏症，控制手術或創傷期間的出血，以及其他需要快速補充纖維蛋白原的情況。

纖維蛋白原濃縮物市場的主要促進因素是出血性疾病和需要快速止血的外科手術的日益增多，以及人們對標靶血液管理療法的認知和應用不斷提高。血漿分餾和重組技術的進步，以及對更安全、無病原體和高純度血液製品的需求不斷成長，也推動了市場成長。此外，人口老化、創傷和心血管手術發生率的上升，以及新興地區醫療基礎設施的持續改善，也促進了對纖維蛋白原濃縮物需求的成長。

主要企業包括CSL Behring、LFB集團、上海瑞斯血液製品有限公司、江西博亞生物製藥有限公司和綠十字生物製品有限公司。前五名生產商佔據了全球約90%的市場。亞太地區是最大的消費市場，約佔60%，其次是美洲和歐洲，兩者總合佔30%以上。依產品類型分類，人纖維蛋白原濃縮物是最大的細分市場，佔超過99%的市場。按應用領域分類，外科手術是最大的應用領域。

本報告旨在全面概述全球人類纖維蛋白原市場，重點關注總銷售量、銷售收入、價格、主要企業佔有率和排名，並按地區、國家、類型和應用進行分析。

本報告提供2020年至2031年人類纖維蛋白原市場規模、估算和預測的歷史數據和預測數據，數據涵蓋銷售量（公斤）和銷售收入，並以2024年為基準年。定量和定性分析有助於讀者制定業務/成長策略、評估市場競爭格局、分析公司在當前市場中的地位，並就人類纖維蛋白原做出明智的商業決策。

目錄

第1章 市場概覽

  • 人類纖維蛋白原產品簡介
  • 全球人類纖維蛋白原市場規模預測
  • 人類纖維蛋白原市場趨勢及促進因素
  • 先決條件和限制
  • 調查目的
  • 目標年份

第2章 公司競爭分析

  • 全球人類纖維蛋白原公司收入排名（2024 年）
  • 全球各公司人類纖維蛋白原收入（2020-2025 年）
  • 全球人類纖維蛋白原銷售量排名（2024 年）
  • 全球各公司人類纖維蛋白原銷售量（2020-2025 年）
  • 全球各公司人類纖維蛋白原平均價格（2020-2025 年）
  • 主要人類纖維蛋白原生產商的製造地和總部分佈狀況
  • 主要製造商提供的人類纖維蛋白原產品
  • 大型生產商何時開始大規模生產人類纖維蛋白原？
  • 人類纖維蛋白原市場競爭分析
  • 併購、擴張

第3章 依類型細分

  • 按類型介紹
    • 人類纖維蛋白原濃縮物
    • 動物纖維蛋白原濃縮物
  • 全球人類纖維蛋白原銷售額（按類型分類）
  • 全球人類纖維蛋白原銷售量（按類型分類）
  • 全球各類人類纖維蛋白原平均價格（2020-2031 年）

第4章 按應用進行細分

  • 透過申請
    • 先天性纖維蛋白原缺乏症
    • 外科手術
    • 其他
  • 全球人類纖維蛋白原按應用領域分列的銷售額
  • 全球人類纖維蛋白原銷售量）
  • 全球平均人類纖維蛋白原價格（按用途分類）（2020-2031 年）

第5章 區域細分

  • 全球人類纖維蛋白原銷售額（按地區分類）
  • 全球人類纖維蛋白原銷售量（按地區分類）
  • 全球各地區平均人類纖維蛋白原價格（2020-2031 年）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第6章 按主要國家和地區分類

  • 主要國家/地區人纖維蛋白原銷售額成長趨勢（2020 年 vs. 2024 年 vs. 2031 年）
  • 主要國家的人類纖維蛋白原銷售額和銷量
  • 美國
  • 歐洲
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度

第7章 公司簡介

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

第8章：產業鏈分析

第9章 研究結果與結論

第10章附錄

The global market for Human Fibrinogen was estimated to be worth US$ 1259 million in 2024 and is forecast to a readjusted size of US$ 2562 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Human Fibrinogen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Human Fibrinogen is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.

The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Fibrinogen by region & country, by Type, and by Application.

The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.

Market Segmentation

By Company

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

Segment by Type

  • Human Fibrinogen Concentrate
  • Animal Fibrinogen Concentrate

Segment by Application

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Human Fibrinogen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Human Fibrinogen Product Introduction
  • 1.2 Global Human Fibrinogen Market Size Forecast
    • 1.2.1 Global Human Fibrinogen Sales Value (2020-2031)
    • 1.2.2 Global Human Fibrinogen Sales Volume (2020-2031)
    • 1.2.3 Global Human Fibrinogen Sales Price (2020-2031)
  • 1.3 Human Fibrinogen Market Trends & Drivers
    • 1.3.1 Human Fibrinogen Industry Trends
    • 1.3.2 Human Fibrinogen Market Drivers & Opportunity
    • 1.3.3 Human Fibrinogen Market Challenges
    • 1.3.4 Human Fibrinogen Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Human Fibrinogen Players Revenue Ranking (2024)
  • 2.2 Global Human Fibrinogen Revenue by Company (2020-2025)
  • 2.3 Global Human Fibrinogen Players Sales Volume Ranking (2024)
  • 2.4 Global Human Fibrinogen Sales Volume by Company Players (2020-2025)
  • 2.5 Global Human Fibrinogen Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Human Fibrinogen Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Human Fibrinogen Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Human Fibrinogen
  • 2.9 Human Fibrinogen Market Competitive Analysis
    • 2.9.1 Human Fibrinogen Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Human Fibrinogen Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Fibrinogen Concentrate
    • 3.1.2 Animal Fibrinogen Concentrate
  • 3.2 Global Human Fibrinogen Sales Value by Type
    • 3.2.1 Global Human Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Human Fibrinogen Sales Value, by Type (2020-2031)
    • 3.2.3 Global Human Fibrinogen Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Human Fibrinogen Sales Volume by Type
    • 3.3.1 Global Human Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Human Fibrinogen Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Human Fibrinogen Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Human Fibrinogen Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Congenital Fibrinogen Deficiency
    • 4.1.2 Surgical Procedures
    • 4.1.3 Others
  • 4.2 Global Human Fibrinogen Sales Value by Application
    • 4.2.1 Global Human Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Human Fibrinogen Sales Value, by Application (2020-2031)
    • 4.2.3 Global Human Fibrinogen Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Human Fibrinogen Sales Volume by Application
    • 4.3.1 Global Human Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Human Fibrinogen Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Human Fibrinogen Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Human Fibrinogen Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Human Fibrinogen Sales Value by Region
    • 5.1.1 Global Human Fibrinogen Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Human Fibrinogen Sales Value by Region (2020-2025)
    • 5.1.3 Global Human Fibrinogen Sales Value by Region (2026-2031)
    • 5.1.4 Global Human Fibrinogen Sales Value by Region (%), (2020-2031)
  • 5.2 Global Human Fibrinogen Sales Volume by Region
    • 5.2.1 Global Human Fibrinogen Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Human Fibrinogen Sales Volume by Region (2020-2025)
    • 5.2.3 Global Human Fibrinogen Sales Volume by Region (2026-2031)
    • 5.2.4 Global Human Fibrinogen Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Human Fibrinogen Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Human Fibrinogen Sales Value, 2020-2031
    • 5.4.2 North America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Human Fibrinogen Sales Value, 2020-2031
    • 5.5.2 Europe Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Human Fibrinogen Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Human Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Human Fibrinogen Sales Value, 2020-2031
    • 5.7.2 South America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Human Fibrinogen Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Human Fibrinogen Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Human Fibrinogen Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Human Fibrinogen Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Human Fibrinogen Sales Value, 2020-2031
    • 6.3.2 United States Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Human Fibrinogen Sales Value, 2020-2031
    • 6.4.2 Europe Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Human Fibrinogen Sales Value, 2020-2031
    • 6.5.2 China Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Human Fibrinogen Sales Value, 2020-2031
    • 6.6.2 Japan Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Human Fibrinogen Sales Value, 2020-2031
    • 6.7.2 South Korea Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Human Fibrinogen Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Human Fibrinogen Sales Value, 2020-2031
    • 6.9.2 India Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Human Fibrinogen Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CSL Behring
    • 7.1.1 CSL Behring Company Information
    • 7.1.2 CSL Behring Introduction and Business Overview
    • 7.1.3 CSL Behring Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 CSL Behring Human Fibrinogen Product Offerings
    • 7.1.5 CSL Behring Recent Development
  • 7.2 LFB Group
    • 7.2.1 LFB Group Company Information
    • 7.2.2 LFB Group Introduction and Business Overview
    • 7.2.3 LFB Group Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 LFB Group Human Fibrinogen Product Offerings
    • 7.2.5 LFB Group Recent Development
  • 7.3 Shanghai RAAS Blood Products
    • 7.3.1 Shanghai RAAS Blood Products Company Information
    • 7.3.2 Shanghai RAAS Blood Products Introduction and Business Overview
    • 7.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Offerings
    • 7.3.5 Shanghai RAAS Blood Products Recent Development
  • 7.4 China Resources Boya Bio-pharmaceutical
    • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
    • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
    • 7.4.3 China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 China Resources Boya Bio-pharmaceutical Human Fibrinogen Product Offerings
    • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
  • 7.5 Hualan Biological Engineering
    • 7.5.1 Hualan Biological Engineering Company Information
    • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
    • 7.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hualan Biological Engineering Human Fibrinogen Product Offerings
    • 7.5.5 Hualan Biological Engineering Recent Development
  • 7.6 Harbin Pacific Biopharmaceutical
    • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
    • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
    • 7.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings
    • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
  • 7.7 China Meheco Group
    • 7.7.1 China Meheco Group Company Information
    • 7.7.2 China Meheco Group Introduction and Business Overview
    • 7.7.3 China Meheco Group Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 China Meheco Group Human Fibrinogen Product Offerings
    • 7.7.5 China Meheco Group Recent Development
  • 7.8 Octapharma
    • 7.8.1 Octapharma Company Information
    • 7.8.2 Octapharma Introduction and Business Overview
    • 7.8.3 Octapharma Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Octapharma Human Fibrinogen Product Offerings
    • 7.8.5 Octapharma Recent Development

8 Industry Chain Analysis

  • 8.1 Human Fibrinogen Industrial Chain
  • 8.2 Human Fibrinogen Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Human Fibrinogen Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Human Fibrinogen Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Human Fibrinogen Market Trends
  • Table 2. Human Fibrinogen Market Drivers & Opportunity
  • Table 3. Human Fibrinogen Market Challenges
  • Table 4. Human Fibrinogen Market Restraints
  • Table 5. Global Human Fibrinogen Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Human Fibrinogen Revenue Market Share by Company (2020-2025)
  • Table 7. Global Human Fibrinogen Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Human Fibrinogen Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Human Fibrinogen Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Human Fibrinogen Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Human Fibrinogen Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Human Fibrinogen
  • Table 13. Global Human Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Human Fibrinogen Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Human Fibrinogen Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Human Fibrinogen Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Human Fibrinogen Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Human Fibrinogen Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Human Fibrinogen Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Human Fibrinogen Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Human Fibrinogen Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Human Fibrinogen Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Human Fibrinogen Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Human Fibrinogen Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Human Fibrinogen Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Human Fibrinogen Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Human Fibrinogen Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Human Fibrinogen Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Human Fibrinogen Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Human Fibrinogen Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Human Fibrinogen Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Human Fibrinogen Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Human Fibrinogen Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Human Fibrinogen Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Human Fibrinogen Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Human Fibrinogen Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Human Fibrinogen Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Human Fibrinogen Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Human Fibrinogen Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Human Fibrinogen Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Human Fibrinogen Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Human Fibrinogen Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Human Fibrinogen Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Human Fibrinogen Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Human Fibrinogen Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Human Fibrinogen Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Human Fibrinogen Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Human Fibrinogen Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Human Fibrinogen Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Human Fibrinogen Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Human Fibrinogen Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Human Fibrinogen Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Human Fibrinogen Sales Volume, (2026-2031) & (Kg)
  • Table 57. CSL Behring Company Information
  • Table 58. CSL Behring Introduction and Business Overview
  • Table 59. CSL Behring Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. CSL Behring Human Fibrinogen Product Offerings
  • Table 61. CSL Behring Recent Development
  • Table 62. LFB Group Company Information
  • Table 63. LFB Group Introduction and Business Overview
  • Table 64. LFB Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. LFB Group Human Fibrinogen Product Offerings
  • Table 66. LFB Group Recent Development
  • Table 67. Shanghai RAAS Blood Products Company Information
  • Table 68. Shanghai RAAS Blood Products Introduction and Business Overview
  • Table 69. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Shanghai RAAS Blood Products Human Fibrinogen Product Offerings
  • Table 71. Shanghai RAAS Blood Products Recent Development
  • Table 72. China Resources Boya Bio-pharmaceutical Company Information
  • Table 73. China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • Table 74. China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. China Resources Boya Bio-pharmaceutical Human Fibrinogen Product Offerings
  • Table 76. China Resources Boya Bio-pharmaceutical Recent Development
  • Table 77. Hualan Biological Engineering Company Information
  • Table 78. Hualan Biological Engineering Introduction and Business Overview
  • Table 79. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 80. Hualan Biological Engineering Human Fibrinogen Product Offerings
  • Table 81. Hualan Biological Engineering Recent Development
  • Table 82. Harbin Pacific Biopharmaceutical Company Information
  • Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • Table 84. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 85. Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings
  • Table 86. Harbin Pacific Biopharmaceutical Recent Development
  • Table 87. China Meheco Group Company Information
  • Table 88. China Meheco Group Introduction and Business Overview
  • Table 89. China Meheco Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 90. China Meheco Group Human Fibrinogen Product Offerings
  • Table 91. China Meheco Group Recent Development
  • Table 92. Octapharma Company Information
  • Table 93. Octapharma Introduction and Business Overview
  • Table 94. Octapharma Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 95. Octapharma Human Fibrinogen Product Offerings
  • Table 96. Octapharma Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Human Fibrinogen Downstream Customers
  • Table 100. Human Fibrinogen Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Human Fibrinogen Product Picture
  • Figure 2. Global Human Fibrinogen Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Human Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Human Fibrinogen Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Human Fibrinogen Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Human Fibrinogen Report Years Considered
  • Figure 7. Global Human Fibrinogen Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Human Fibrinogen Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Fibrinogen Revenue in 2024
  • Figure 10. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Human Fibrinogen Concentrate Picture
  • Figure 12. Animal Fibrinogen Concentrate Picture
  • Figure 13. Global Human Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Human Fibrinogen Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Human Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Human Fibrinogen Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Human Fibrinogen Price by Type (2020-2031) & (USD/Kg)
  • Figure 18. Product Picture of Congenital Fibrinogen Deficiency
  • Figure 19. Product Picture of Surgical Procedures
  • Figure 20. Product Picture of Others
  • Figure 21. Global Human Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Human Fibrinogen Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Human Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 24. Global Human Fibrinogen Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Human Fibrinogen Price by Application (2020-2031) & (USD/Kg)
  • Figure 26. North America Human Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Human Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Human Fibrinogen Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Human Fibrinogen Sales Volume (%), (2020-2031)
  • Figure 38. United States Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Human Fibrinogen Industrial Chain
  • Figure 60. Human Fibrinogen Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed